5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT’S EXPERIENCE.

Detalles Bibliográficos
Autores principales: Manganas, K.M., Kotsiafti, K.A., Xydaki, X.A., Patsourakos, D.P., Aggeli, K.A., Savvidis, S.C., Koskinas, K.I., Delicou, S.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112588/
http://dx.doi.org/10.1097/01.HS9.0000928240.02267.88
Descripción
Sumario:

Ejemplares similares